Men’s Health Initiative

Time-for-Action

  • According to a 2021 study published in the American Journal of Epidemiology, generation X and millennials are in worse health than their parents and grandparents were at their age.
  • Recent years have seen a well-documented national rise in deaths from suicide, drug abuse and problem drinking, which some experts have labeled “deaths of despair.”
  • Insights from this landmark study sets the stage for action:
    • “The declining health among younger generations is not just an individual problem, but more a societal problem.  Society needs to change the environment, reduce inequality and enhance job security for younger generations.”
  • Research from around the world, continues to emphasize a disparity in longevity for men. The World Health Organization’s 2015 study examining benchmarks for human progress found that on a global scale the life expectancy for males at birth was 69.1 years, while that for women was 73.8 years.

Investment Strategy

  • Now is the time to invest into initiatives intended to reverse these trends and develop science-based approaches to address the erosion of men’s health.
    • Healthy men are a vital and necessary to human society and the innovation ecosystem’s that fuel our global economy.
    • Men’s health should be recognized alongside women’s health and child health as vital inputs into economic prosperity and national security.
    • Philanthropic support for research programs focusing on men’s health can be expanded to include a focus on Gen-X and millennial men.
    • Stakeholders investing into this research should take note of the market forces surrounding the development of consumer products addressing men’s health which is forecast to reach $166 billion by 2022.

TESTICULAR Cancer Research

Testicular cancer is the focus and improving men’s quality of life is the goal. The Incidence rates of testicular cancer have been increasing in the US and many countries since the mid-20th century without clear explanation.

  • Testicular cancer is the most frequently diagnosed cancer among men aged 20–34, with a median age of 33 at diagnosis.
  • The percent of testicular cancer deaths is highest among men aged 20–34, with a median age of 41 at death.

The increase in testicular cancer is mostly in seminomas. The mechanisms responsible for this increase remains to be defined. Seminomas are a malignant neoplasm and is one of the most treatable and curable cancers, with a survival rate above 95% if discovered in the early stages.

Research & Development Portfolio

Research programs investigating the initiation of testicular cancer in the Generation X and millennial male populations can be expanded to include the following:

  • Identify new predictive and diagnostic biomarkers for early detection
  • Evaluate the effectiveness of nutritional therapies selected to maintain healthy testosterone levels
  • Learning strategies to support mental health and risk reduction
  • Leverage our research insights to develop nutritional supplements tailored to meet the needs of men based upon their associated risk profiles